Ryan Murr > Gibson, Dunn & Crutcher LLP > San Francisco, United States > Lawyer Profile
Gibson, Dunn & Crutcher LLP Offices
555 Mission Street, Suite 3000
San Francisco, CA 94105-0921
CALIFORNIA
United States
- Firm Profile
- Go to...
Ryan Murr
Work Department
Life Sciences, Corporate, Capital Markets
Position
Co-chair, global life sciences practice, Ryan focuses on representing operating companies and investors in the biotechnology, pharmaceutical, diagnostics and medical device industries in connection with securities offerings, corporate governance matters and business combination transactions. He serves as principal outside counsel for publicly-traded companies and venture-backed companies, advising management teams and boards of directors on general corporate matters, securities offerings, SEC reporting, corporate governance, licensing transactions and mergers & acquisitions. He also advises investment funds (private equity funds, hedge funds, venture funds and royalty buyout funds) in connection with investments in life sciences companies and assets.
Career
For more information, please visit https://www.gibsondunn.com/lawyer/murr-ryan-a/.
Lawyer Rankings
United States > Healthcare > Life sciences
The life sciences team at Gibson, Dunn & Crutcher LLP advises a diverse client roster of life sciences and investment companies, including Gilead Sciences, the Dana-Farber Cancer Institute, and Amyris. Jane Love leads the team alongside Ryan Murr, working from New York and San Francisco, respectively. Love routinely acts in patent litigations concerning biologics, RNA therapies, and therapeutic nucleic acids, while Murr advises investors targeting the medical device and diagnostics, biotech, and pharmaceutical industries on securities offerings and licensing transactions. Working out of the San Francisco office, Brandon Berns assists clients with corporate transactional matters, while of counsel Todd Trattner works with research institutes, diagnostics companies, and biotech companies – both public and private – on IP transactions. Charlotte Jacobsen joined the New York practice from Ropes & Gray LLP in April 2022, contributing her experience in handling chemical and biotech patent and licensing disputes, often appearing before the PTAB, AAA, and ICC.
Lawyer Rankings
Top Tier Firm Rankings
- Antitrust > Cartel
- Antitrust > Civil litigation/class actions: defense
- Government > Government relations
- Environment > Environment: litigation
- Dispute resolution > General commercial disputes
- Dispute resolution > International litigation
- Labor and employment > Labor and employment disputes (including collective actions)
- Real estate > Land use/zoning
- Real estate > Real estate finance
- Finance > Commercial lending
- Labor and employment > Labor and employment disputes (including collective actions)
- Labor and employment > Labor and employment disputes (including collective actions)
- Labor and employment > Labor and employment disputes (including collective actions)
- Media, technology and telecoms > Media and entertainment: litigation
- Real estate > Real estate finance
- Transport > Aviation and air travel: finance
- Media, technology and telecoms > Media and entertainment: transactional
- Labor and employment > Labor and employment disputes (including collective actions)
- Media, technology and telecoms > Technology transactions
- Real estate > Real estate finance
- Media, technology and telecoms > Outsourcing
- Transport > Rail and road: litigation and regulation
- Real estate > Real estate
- Real estate > Real estate finance
- Dispute resolution > Securities litigation: defense
Firm Rankings
- Insurance > Advice to insurers
- Finance > Capital markets: debt offerings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Energy > Energy regulation: electric power
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Media, technology and telecoms > Media and entertainment: transactional
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Finance > Project finance
- Energy > Renewable/alternative power
- Finance > Restructuring (including bankruptcy): corporate
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Tax > US taxes: contentious
- Tax > US taxes: non-contentious
- Finance > Capital markets: high-yield debt offerings
- M&A/corporate and commercial > Corporate governance
- Energy > Energy litigation: oil and gas
- Dispute resolution > Financial services litigation
- Government > Government contracts
- Dispute resolution > Leading trial lawyers
- Antitrust > Merger control
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Industry focus > Sport
- Media, technology and telecoms > Technology transactions
- Finance > Commercial lending
- Finance > Capital markets: equity offerings
- International Trade > Customs, export controls and economic sanctions
- Energy > Energy litigation: electric power
- Energy > Energy regulation: oil and gas
- Dispute resolution > International arbitration
- Healthcare > Life sciences
- Finance > Structured finance: derivatives and structured products
- M&A/corporate and commercial > Venture capital and emerging companies
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Dispute resolution > Corporate investigations and white-collar criminal defense